News

Filter

Current filters:

Namenda

1 to 9 of 68 results

Actavis files emergency appeal against District Court decision on Namenda

Actavis files emergency appeal against District Court decision on Namenda

16-12-2014

Ireland-headquartered generics major Actavis is filing an emergency appeal to the US Court of Appeals…

ActavisGenericsLegalNamendaNeurologicalUSA

Court tells Actavis it must continue Namenda IR distribution

Court tells Actavis it must continue Namenda IR distribution

12-12-2014

Ireland-headquartered generic drugmaker Actavis confirmed that Judge Robert Sweet of the US District…

ActavisLegalMarkets & MarketingNamendaNeurologicalPharmaceuticalUSA

Adamas Pharma earns $40 milestone in Forest deal

10-01-2014

California, USA-based Adamas Pharmaceuticals revealed yesterday (January 9) that it has received $40…

Adamas PharmaceuticalsdonepezilFinancialForest LaboratoriesMDX-8704NamendaNeurologicalPharmaceuticalResearch

Insights on the US Alzheimer's disease market

03-12-2012

The treatment of Alzheimer's disease (AD) offers a compelling commercial opportunity for the pharmaceutical…

AriceptEisaiExelonForest LaboratoriesGenericsMarkets & MarketingNamendaNeurologicalNorth AmericaNovartisPfizerPharmaceutical

Alzheimer's drug memantine fails to reduce significant agitation

03-05-2012

Memantine, a drug prescribed for Alzheimer's disease, does not ease clinically significant agitation…

EbixaMemantine HCLNamendaNeurologicalPharmaceuticalResearch

1 to 9 of 68 results

COMPANY SPOTLIGHT

Menarini

Back to top